130 related articles for article (PubMed ID: 31752546)
1. Assessment of critical material attributes of polyethylene oxide for formulation of prolonged-release tablets.
Draksler P; Janković B; Abramović Z; Lavrič Z; Meden A
Drug Dev Ind Pharm; 2019 Dec; 45(12):1949-1958. PubMed ID: 31752546
[TBL] [Abstract][Full Text] [Related]
2. Design and Evaluation of Hydrophilic Matrix System Containing Polyethylene Oxides for the Zero-Order Controlled Delivery of Water-Insoluble Drugs.
Wang L; Chen K; Wen H; Ouyang D; Li X; Gao Y; Pan W; Yang X
AAPS PharmSciTech; 2017 Jan; 18(1):82-92. PubMed ID: 26883263
[TBL] [Abstract][Full Text] [Related]
3. Comparative evaluation of drug release from aged prolonged polyethylene oxide tablet matrices: effect of excipient and drug type.
Shojaee S; Kaialy W; Cumming KI; Nokhodchi A
Pharm Dev Technol; 2016 Mar; 21(2):189-95. PubMed ID: 25410967
[TBL] [Abstract][Full Text] [Related]
4. Applications of poly(ethylene oxide) in controlled release tablet systems: a review.
Ma L; Deng L; Chen J
Drug Dev Ind Pharm; 2014 Jul; 40(7):845-51. PubMed ID: 24001212
[TBL] [Abstract][Full Text] [Related]
5. Extended release of a large amount of highly water-soluble diltiazem hydrochloride by utilizing counter polymer in polyethylene oxides (PEO)/polyethylene glycol (PEG) matrix tablets.
Kojima H; Yoshihara K; Sawada T; Kondo H; Sako K
Eur J Pharm Biopharm; 2008 Oct; 70(2):556-62. PubMed ID: 18606223
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the drug solubility and rush ageing on drug release performance of various model drugs from the modified release polyethylene oxide matrix tablets.
Shojaee S; Nokhodchi A; Maniruzzaman M
Drug Deliv Transl Res; 2017 Feb; 7(1):111-124. PubMed ID: 27873080
[TBL] [Abstract][Full Text] [Related]
7. Effect of drug solubility on polymer hydration and drug dissolution from polyethylene oxide (PEO) matrix tablets.
Li H; Hardy RJ; Gu X
AAPS PharmSciTech; 2008; 9(2):437-43. PubMed ID: 18431663
[TBL] [Abstract][Full Text] [Related]
8. [The erosion behaviour of matrix tablets using polyethylene oxide matrices as hydrophilic polymer].
Nie SF; Tang H; Guo H; Pan WS
Yao Xue Xue Bao; 2005 Oct; 40(10):882-7. PubMed ID: 16408802
[TBL] [Abstract][Full Text] [Related]
9. Polyethylene oxide and its controlled release properties in hydrophilic matrix tablets for oral administration.
Vanza JD; Patel RB; Dave RR; Patel MR
Pharm Dev Technol; 2020 Dec; 25(10):1169-1187. PubMed ID: 32772604
[TBL] [Abstract][Full Text] [Related]
10. Mechanistic Approach to Understanding the Influence of USP Apparatus I and II on Dissolution Kinetics of Tablets with Different Operating Release Mechanisms.
Lu Z; Fassihi R
AAPS PharmSciTech; 2017 Feb; 18(2):462-472. PubMed ID: 27106916
[TBL] [Abstract][Full Text] [Related]
11. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.
Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS
Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538
[TBL] [Abstract][Full Text] [Related]
12. Formulation development and human in vitro-in vivo correlation for a novel, monolithic controlled-release matrix system of high load and highly water-soluble drug niacin.
Turner S; Federici C; Hite M; Fassihi R
Drug Dev Ind Pharm; 2004 Sep; 30(8):797-807. PubMed ID: 15521326
[TBL] [Abstract][Full Text] [Related]
13. Polyethylene Oxide (PEO) Molecular Weight Effects on Abuse-Deterrent Properties of Matrix Tablets.
Meruva S; Donovan MD
AAPS PharmSciTech; 2019 Dec; 21(1):28. PubMed ID: 31858320
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo evaluation of controlled-release matrix tablets of highly water-soluble drug applying different mw polyethylene oxides (PEO) as retardants.
Wen H; Li X; Li Y; Wang H; Wang Y; Wang T; Pan W; Yang X
Drug Dev Ind Pharm; 2018 Apr; 44(4):544-552. PubMed ID: 29130753
[TBL] [Abstract][Full Text] [Related]
15. The impact of the injection mold temperature upon polymer crystallization and resulting drug release from immediate and sustained release tablets.
Van Renterghem J; Dhondt H; Verstraete G; De Bruyne M; Vervaet C; De Beer T
Int J Pharm; 2018 Apr; 541(1-2):108-116. PubMed ID: 29409747
[TBL] [Abstract][Full Text] [Related]
16. Dissolution behaviour of hydrophilic matrix tablets containing two different polyethylene oxides (PEOs) for the controlled release of a water-soluble drug. Dimensionality study.
Maggi L; Segale L; Torre ML; Ochoa ME; Conte U
Biomaterials; 2002 Feb; 23(4):1113-9. PubMed ID: 11791914
[TBL] [Abstract][Full Text] [Related]
17. Molecular-Level Control of Ciclopirox Olamine Release from Poly(ethylene oxide)-Based Mucoadhesive Buccal Films: Exploration of Structure-Property Relationships with Solid-State NMR.
Urbanova M; Gajdosova M; Steinhart M; Vetchy D; Brus J
Mol Pharm; 2016 May; 13(5):1551-63. PubMed ID: 27019088
[TBL] [Abstract][Full Text] [Related]
18. Push-Pull Controlled Drug Release Systems: Effect of Molecular Weight of Polyethylene Oxide on Drug Release.
Nakajima T; Takeuchi I; Ohshima H; Terada H; Makino K
J Pharm Sci; 2018 Jul; 107(7):1896-1902. PubMed ID: 29548974
[TBL] [Abstract][Full Text] [Related]
19. Correlation between drug dissolution and polymer hydration: a study using texture analysis.
Li H; Gu X
Int J Pharm; 2007 Sep; 342(1-2):18-25. PubMed ID: 17548178
[TBL] [Abstract][Full Text] [Related]
20. Properties of sustained-release tablets prepared by hot-melt extrusion.
Zhang F; McGinity JW
Pharm Dev Technol; 1999 May; 4(2):241-50. PubMed ID: 10231885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
